Pathway Medical lands generous $40M to treat arterial disease
Pathway Medical Technologies, maker of a non-invasive catheter capable of removing all kinds of artery blockages and build-up, says it just scored $40 million in a fourth round of funding — a pretty high figure for a life science device manufacturer these days. Only about… Continue Reading
Concentric Medical closes $15M to ease stroke symptoms
Concentric Medical, developer of minimally invasive devices used to remove blood clots in ischemic stroke patients, took $15 million in new venture backing to expand its product portfolio and run more clinical trials. The Mountain View, Calif. company says it ended 2008 on a strong… Continue Reading
Luca shovels in $76M for coal-to-gas technology
Coal is no longer the dirty word it once was. And there’s no better indication than the $75.9 million recently pulled in by Luca Technologies, a company that engineers microbes to produce methane gas from coal. This brand of innovation could be good news all… Continue Reading
Migraine sufferers look elsewhere as Cierra buckles
The headache is over for medical device maker Cierra. Actually it’s all over. The Redwood City, Calif.-based company is out of business after failing to draft enough participants into a clinical trial of a catheter-based technology purported to reduce migraines, VentureWire reported. It takes $29… Continue Reading
Life-science briefing: Monday, March 10, 2008
TODAY’S HEADLINES:
BrainCells raises $30M for neuroregeneration drugs (release)
EKR Therapeutics takes in $50M plus $95M in debt for pain, heart drugs (release)
Wright Medical acquires Berkeley’s Inbone Tech for $24M (release)
Argolyn Bioscience names Nixon Ellis as CEO (release)
BrainCells raises $30M for neuroregeneration drugs – San Diego’s BrainCells, a… Continue Reading
Life sciences briefing: Monday, Jan. 14, 2008
TODAY’S HEADLINES:
Autonomic Technologies raises $3M for neurostimulators (PE Hub)
Canopy Financial raises $15M for outsourced healthcare management (release)
Cancer-drug developer AmpliMed draws $5M (PE Hub)
Caprotec Bioanalytics receives €6M for protein-analysis tech (release)
ProtAffin draws additional €1.4M for anti-inflammatory drugs (release)
Toxicology-services firm Bridge Labs takes in $18M (release)
Dental-compound maker… Continue Reading
Life sciences briefing: Wednesday, Oct. 31, 2007
Featured companies: AerovectRx, Dicerna Pharmaceuticals, Harmony Information Systems, Intelligent Hospital Systems, Merrion Pharmaceuticals, Syntaxin, SymBio Pharmaceuticals
UPDATED: Expanded items on Harmony Info, SymBio Pharma and Merrion Pharma, added Dicerna item.
UPDATE REDUX: Added Syntaxin item.
U.K. biotech Syntaxin raises £16M for pain and nervous-system drugs — Syntaxin, a U.K. biotech focused… Continue Reading
Life sciences briefing: Thursday, Oct. 25, 2007
Featured companies: BioVex, Cavadis, Innovention, Paratek Pharmaceuticals, Phase Bioscience, Reliant Pharmaceuticals, Xencor
UPDATED: Expanded Paratek and Xencor items.
Paratek Pharma raises $40M for new antibiotics — Boston’s Paratek Pharmaceuticals, a biotech working on new antibiotics to treat drug-resistant bacterial infections, raised a first tranche of a $40 million eighth… Continue Reading
LUCA raises $20M more to convert dirty coal into natural gas
LUCA Technologies, a Golden, Colo. company developing technology to convert dirty coal into natural gas, has raised $20 million more in financing.
The company joins a host of others working on similar conversion technologies. LUCA’s technology is different in that it works underground, seeding changes to… Continue Reading
Life sciences briefing: Monday, Aug. 6, 2007
(UPDATED at 5:05 p.m. PDT; see below.)
(As part of my ongoing effort to strike the right balance between keeping up with venture-business news and writing more analysis, I’m inaugurating a daily briefing that will collect deal-related news items from the life sciences in one place. I’ll… Continue Reading
Amgen snaps up another biotech startup, Alantos Pharma, for $300M
Amgen suddenly has a voracious appetite for startups. In its second deal this week, the biotech giant acquired Cambridge, Mass., biotech Alantos Pharmaceuticals for $300 million in cash. (The release is here.)
Founded in Heidelberg, Germany in 1999, Alantos changed its name from Therascope in… Continue Reading
Intechra, electronics recycler, gets $30M
Intechra Holdings, a Jackson, Miss. company that recycles electronics, said it has raised $30 million in a third round of financing, making it just the latest in a hot trend of green investing.
See the company’s statement here.
The funding was led by Richland Ventures, of Nashville,… Continue Reading
Cancer-drug maker Aveo raises $53M
Aveo Pharmaceuticals, a Cambridge, Mass. cancer-drug company, raised $53 million in a fourth round of funding from a coalition of mostly blue-chip life-science investors.
New investors included Biogen Idec, Bessemer Venture Partners, Merlin BioMed Group, Mitsubishi UFJ Financial Group and Vatera Holdings, an investment vehicle… Continue Reading